Skip to main content
Premium Trial:

Request an Annual Quote

Agilent, Sage Partner on Next-gen Sequencing Applications

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Agilent Technologies and Sage Science today announced a co-marketing deal covering each other's technologies for next-generation sequencing applications.

The deal covers Agilent's 2100 Bioanalyzer for detecting and quantifying nucleic acids and Sage's Pippin Prep DNA size selection system. In addition to co-promoting the platforms, the partners will develop application studies that leverage the combined capabilities of the two systems.

Financial and other terms of the deal were not disclosed.

The 2100 Bioanalyzer is a microfluidics-based system for sizing, quantification, and quality control of DNA, RNA, proteins, and cells. The Pippin Prep is an electrophoretic platform for preparing size-fractionated DNA samples.

Proper preparation and quality control of the input sample and the library are crucial for achieving high-fidelity data in next-gen sequencing, the partners said in a statement. Combining the 2100 Bioanalyzer with the Pippin Prep will advance and streamline sample preparation, they added.

In October, Sage announced a co-marketing deal for its Pippin Prep system with Illumina's next-gen sequencers.

The Scan

Charged with Sanction Violations

A former professor has been charged with exporting genetic sequencing equipment to Iran in violation of US sanctions, the Miami Herald reports.

Prenetics to Go Public Through SPAC

Prenetics, a Hong Kong-based genomic and diagnostic company, is going public through a SPAC merger, according to 360Dx.

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.